DEVELOPMENT OF PEDIATRIC TUBERCULOSIS TREATMENT
$300,000N43FY2021AINIH
Zymeron Corporation, Durham NC
Investigators
Abstract
To develop tuberculosis therapeutic formulations for pediatric patients.
View original record on NIH RePORTER →Zymeron Corporation, Durham NC
To develop tuberculosis therapeutic formulations for pediatric patients.
View original record on NIH RePORTER →